Laboratory Diagnostics for the Detection of Influenza A/B & RSV

Similar documents
How Rapid Influenza Testing Reduces Patient Isolation Days

CMV Diagnostic Strategies: Current and Future

October Influenza Testing for the Season. Lauren Anthony, MD, MT(ASCP)SBB Medical Director, Allina Medical Laboratories

The QIAsymphony RGQ as a platform for laboratory developed tests

Retrospective and Prospective Verification of the Cepheid Xpert Flu Assay

Appendix B: Provincial Case Definitions for Reportable Diseases

EVALUATION OF THE COBAS LIAT (ROCHE ) AND THE LIAISON MDX (DIASORIN )

Comparison of the Alere i and BD Veritor Assays for the Rapid Detection of Influenza A and B Viruses

Rapid Detection FAQs

Point of care testing for respiratory viruses

Collection (Specimen Source Required on all tests) Sputum: >5 ml required. First morning specimen preferred.

Weekly Influenza & Respiratory Activity: Statistics Summary

Weekly Influenza Activity: Statistics Summary

M. Khanna and S. Visuri

Influenza Laboratory Surveillance DSHS Flu Surveillance Workshop Lesley Brannan, MPH

Respiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic. Webinar Agenda

Role of multiplex PCR in the diagnostics of respiratory viruses. PIGS course November 25 th -26 th 2016 Julia Bielicki AND Sandra Asner

Human Influenza A (Swine Flu) Rapid test

Redefine Performance. BD Veritor. System Revolutionizes Testing at the Point of Care. Fast. Streamlined Workflow Requires minimal hands-on time

Oregon s Weekly Surveillance Report for Influenza and other Respiratory Viruses

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

GeneXpert System. On-Demand Molecular Testing for the Physician Office Laboratory

Molecular Diagnostics at Point of Care When will we get there; and where is there anyway?

point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital

Lab Alert REMINDER: BioFire- FilmArray Respiratory Panel

Highlights. NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Influenza Surveillance Report Week ending January 28, 2017 (Week 4)

Respiratory Pathogen Panel TEM-PCR Test Code:

Rapid-VIDITEST Swine Flu

Human Infection with Novel Influenza A Virus Case Report Form

Georgia Weekly Influenza Report

Test Menu. Infectious Diseases Laboratory. Division of Infectious Diseases Department of Medicine

MENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs

Multiplex-PCR in clinical virology benefits and limitations. Weihenstephan Multiplex-PCR the concept:

Next Generation Rapid Diagnostics

Influenza Report Week 03

Georgia Weekly Influenza Report

Influenza Weekly Surveillance Report

Public Health Laboratory Pandemic Preparedness. Patricia A. Somsel, DrPH Michigan Department of Community Health

Georgia Weekly Influenza Report

Preparing for the Fall Flu Season. Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP

Cases. in Point-of-Care Testing

Point-of-Care Molecular Testing

Performance of the Molecular Alere i Influenza A&B Test Compared to Xpert Flu A/B. Assay

Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) virus infection in China

Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid

In Case of Technical Difficulties

Data at a Glance: February 8 14, 2015 (Week 6)

Flu A, Flu B & RSV H / L. Test kit for 48 determinations. For Professional Use Only 37 C 2 C

INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)

Tarrant County Influenza Surveillance Weekly Report CDC Week 39: Sept 23-29, 2018

Tarrant County Influenza Surveillance Weekly Report CDC Week 35, August 27-September 2, 2017

Molecular Diagnostics at Point of Care It s The Future Already. Ack!

Tarrant County Influenza Surveillance Weekly Report CDC Week 10: March 04-10, 2012

Point of Care Tests for respiratory viruses: impact on clinical outcomes of patients

Influenza Report Week 44

Sample Selection, Collection, Transport: Issues & Challenges

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Enterovirus-D68 (EV-D68) Frequently Asked Questions September 29, 2014 New information in italics

Real-Time PCR Detects Viral Nucleic Acids in Universal Transport Medium (UTM-RT) with Flocked Swabs

Tarrant County Influenza Surveillance Weekly Report CDC Week 02: January 08 14, 2012

Tarrant County Influenza Surveillance Weekly Report CDC Week 06: February 05 11, 2012

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

The Application of molecular POCT for Influenza and Group A Strep Detection

Doctor tests. Vincent Jarlier MD, PhD Pitié-Salpêtrière hospital Paris, France

Influenza Report Week 45

Austin Public Health Epidemiology and Disease Surveillance Unit. Travis County Influenza Surveillance

Influenza Weekly Surveillance Report

Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2012

Sophie S. Arbefeville, MD, 1,2* Ann R. Fickle, SV(ASCP), 2 Patricia Ferrieri, MD 1,2 ABSTRACT

Respiratory Outbreak Update,

Advances in Pathogen Detection and Diagnostic Tools for Infectious Diseases. Maria Rosario Z. Capeding, MD, FPPS, FPIDSP

Influenza Report Week 47

Rapid-VIDITEST. Influenza A+B

Surveillance of influenza in Northern Ireland

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-Upon-Thames TW18 3HR

TEST REQUEST INFORMATION- VIROLOGY

COMPARISON OF THE SOFIA AND VERITOR DIRECT ANTIGEN DETECTION ASSAY SYSTEMS TO IDENTIFY INFLUENZA VIRUSES FROM PATIENT NASOPHARYNGEAL

Information collected from influenza surveillance allows public health authorities to:

Multiplex Syndromic Testing s Effect on Public Health Molecular Testing & Emerging Technology WCLN Workshop April 28, 2016

Tarrant County Influenza Surveillance Weekly Report CDC Week 20: May 11-17, 2014

Understanding Flu Testing

USER GUIDE FOR SPECIMEN COLLECTION

Likelihood that an unsubtypeable Influenza A result. in the Luminex xtag Respiratory Virus Panel. is indicative of novel A/H1N1 (swine-like) influenza

CDHB Infection Prevention and Control Community Liaison

Fecal shedding of rotavirus vaccine in premature babies in the neonatal unit

Weekly Influenza Surveillance Summary

Pediatric Infections caused by the Swine-Origin Influenza A (H1N1) Virus (S-OIV) 5/1/09 Update

Passive surveillance of swiavs in France

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

ARIZONA INFLUENZA SUMMARY

Tis the Season Respiratory that is

1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal swine Influenza A vir

Seasonal Influenza Report

Weekly Influenza Surveillance Report. Week 11

Simplexa Flu A/B & RSV Direct

Evaluation of the Alere i Influenza A&B nucleic acid amplification test using respiratory specimens collected in viral transport medium

GeneXpert HIV-1 Quantitative assay Natasha Samsunder

nstitute of Medicine ommittee on Implementation of Antiviral Medication trategies for an Influenza Pandemic

Transcription:

Laboratory Diagnostics for the Detection of Influenza A/B & RSV T. Mazzulli, MD, FRCPC, FACP Department of Microbiology, UHN/Mount Sinai Hospital Ontario Ministry of Health Public Health Laboratory University of Toronto

Disclosure! I have received grant support funding, speakers honorarium and/or served on advisory board for the following: Bayer Healthcare, Gilead, Boerhinger, Merck, Pfizer! For the current evaluation kits were supplied by Focus Diagnostics Inc. (Simplexa assay) and Inter Medico (GeneXpert assay); No additional support (financial or otherwise was provided)

Objectives! Discuss results of laboratory comparison for the molecular diagnosis of Influenza A/ B and RSV: Altona Influenza A/B and RSV assays Simplexa combined Influenza A/B RSV Direct GeneXpert Influenza A/B assay

Introduction! In many centers, molecular methods have become the standard for the diagnosis of respiratory viruses particularly Influenza A/B and RSV Most are using Real-time PCR assays Specimens include NP swabs/aspirates, BAL samples and less commonly sputum, throat swabs, nasal swabs and lung tissue! Assays may differ in extraction steps required, targets amplified/detected, instrumentation used and time to results

Purpose! To evaluate the sensitivity/specificity, ease of use, and time to results for 3 real-time PCR assays for the detection of Influenza A/B and RSV: Altona Influenza A/B and RSV assays (Current assay combined with extraction using the EasyMag (biomerieux) Simplexa combined Influenza A/B RSV Direct GeneXpert Influenza A/B assay

Methods! Specimens: 149 stored, frozen BAL and NP swabs from January 2009 to July 2012 For Influenza A/B:! 100 tested by all 3 assays! 50 tested by Altona and Simplexa assay only For RSV:! 150 tested by Altona and Simplexa assays only! Definition of True Positives : Influenza A/B At least 2 of 3 assays positive RSV No secondary test available (No GeneXpert RSV assay)

Altona Influenza A/B and RSV Assays EasyMag Rotorgene

Simplexa Flu A/B & RSV Direct Assay Microfluidic Disc 3M Integrated Cycler

GeneXpert Flu A/B Assay Sample Cartridge GeneXpert

Methods! 149 Specimens: 73 negative specimens for Influenza A/B and RSV 30 positive for Influenza A 31 positive for influenza B 15 positive for RSV

Results Influenza A Simplexa Positive Negative Total Positive 27 3* 30 Altona Negative 1 @ 66^ 67 Total 28 69 97 *2/3 GeneXpert negative; @ GeneXpert positive; ^Additional 6 samples with Internal Control Failure

Results Influenza B Simplexa Positive Negative Total Positive 28 3 31 Altona Negative 0 67^ 67 Total 28 70 98 ^Additional 6 samples with Internal Control Failure

Results RSV Simplexa Positive Negative Total Positive 15 0 15 Altona Negative 0 67^ 67 Total 15 67 82 ^Additional 6 samples with Internal Control Failure

Results! Simplexa detected additional/mixed virus infections: 2 RSV positive samples by Altona were positive by Simplexa for RSV and Influenza B 1 Influenza B positive sample by Altona was positive by Simplexa for RSV + Influenza A + Influenza B

Results! Specimens included for GeneXpert had results as follows based on Altona assay: 18 positive for Influenza A 20 positive for Influenza B 14 positive for RSV 47 negative! All were tested by the Simplexa assay

Results Influenza A GeneXpert Positive Negative Total Positive 13 5* 18 Altona Negative 1 @ 60^ 61 Total 14 65 79 *2/5 Simplexa positive; @ Simplexa positive; ^Additional 2 samples with Error or Invalid result

Results Influenza B GeneXpert Positive Negative Total Positive 17 3* 20 Altona Negative 1 60^ 61 Total 18 63 81 *1/3 positive by Simplexa; ^Additional 2 samples with Error or Invalid result

Summary! Given small numbers, no difference detected in sensitivity/specificity of assays! Potential for detection of mixed infections with combo Influenza A/B & RSV assays! Results available: Altona: 210 minutes (up to 65 results) Simplexa: 60 minutes (up to 8 results) GeneXpert: 45 to 60 minutes (individual results)

Thanks to:! Xhermi Trimi! Anthony Mazzulli! John Ng! Lily Law

How to properly collect a respiratory specimen! Thank you for your attention!